Schedule 13G ownership disclosure

Rhythm Pharmaceuticals Inc

Security class unavailable · CUSIP: 76243J105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,226,938
Percent of class
5.4600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-021842
Form type
SC 13G
Filer
RHYTHM PHARMACEUTICALS, INC.
CIK
CIK 1649904
Filed
Feb 13, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub